Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 10 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ESR1
💬1. ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer [9] Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone s ... | Prasterone
Prasterone
💬1. ESR1
| Prasterone | [6] 49 49, 53, 83, 86, 96, 113 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ESR2
💬2. ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer [7] Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, P ... | Prasterone
Prasterone
💬2. ESR2
| Prasterone | [6] 49 49, 53, 83, 86, 96, 113 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
NR3C1
💬3. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Hydrocortisone
Hydrocortisone
💬3. NR3C1
| Hydrocortisone | [10] 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
NR3C1
💬4. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Betamethasone
Betamethasone
💬4. NR3C1
| Betamethasone | [8] 2 2, 28, 46, 65, 83, 90, 96, 235 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
NR3C1
💬5. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬5. NR3C1
| Methylprednisolone | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 [46] 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, ... 5. NR3C1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
NR3C1
💬6. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Hydrocortisone cypionate
Hydrocortisone cypionate
💬6. NR3C1
| Hydrocortisone cypionate | [3] 6 6, 81, 83 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
NR3C1
💬7. NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Hydrocortisone succinate
Hydrocortisone succinate
💬7. NR3C1
| Hydrocortisone succinate | [3] 6 6, 81, 83 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
AR
💬8. AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer [4] Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate canc ... | Prasterone
Prasterone
💬8. AR
| Prasterone | [6] 49 49, 53, 83, 86, 96, 113 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
MC2R
💬9. MC2R
| [5] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome [5] cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secre ... | Cosyntropin
Cosyntropin
💬9. MC2R
| Tetracosactide | [5] 78 78, 83, 113, 145, 222 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
MS4A1
💬10. MS4A1
| [1] Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab
Rituximab
💬10. MS4A1
| Rituximab | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 [48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, ... 10. MS4A1
|